{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:58:53Z","timestamp":1793973533749,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We based our assessment on a previously published review by White et al (1992-2011) and on a systematic review(2012-2017).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The new search identified 328 abstracts. Combining both eras (1992-2011 and 2012-2017), 25 studies were included in the analysis. Four were prospective, 2 described a retrospective analysis of a prospective database, and the others were retrospective. All studies were published after 2004, but the inclusion period of half of them ended before the year 2000. Studies showed variation in the definition of NAFLD, in the incidence of fibrosis\/cirrhosis, in the presence of comorbidities (potentially affecting HCC incidence), and in the type and duration of screening. Considering only studies strictly including patients with or without cirrhosis, the reported incidence of HCC in NAFLD patients\n                      <jats:italic toggle=\"yes\">with<\/jats:italic>\n                      cirrhosis was between 6.7 and 15% at 5 to 10 years, whereas the incidence in NAFLD patients\n                      <jats:italic toggle=\"yes\">without<\/jats:italic>\n                      cirrhosis was 2.7% at 10 years and 23 per 100 000 person-years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma screening in NAFLD patients with cirrhosis is mandatory. However, the currently observed low (and insufficiently documented) incidence of HCC in NAFLD patients without cirrhosis does not justify a systematic surveillance. Research efforts should focus on developing a score, which could aid the clinician in identifying NAFLD patients without cirrhosis who are at higher risk of developing HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002361","type":"journal-article","created":{"date-parts":[[2018,8,5]],"date-time":"2018-08-05T21:56:00Z","timestamp":1533506160000},"page":"39-44","source":"Crossref","is-referenced-by-count":60,"title":["Should Patients With NAFLD\/NASH Be Surveyed for HCC?"],"prefix":"10.1097","volume":"103","author":[{"given":"Maria","family":"Reig","sequence":"first","affiliation":[{"name":"Barcelona Clinic Liver Cancer (BCLC) Group, Radiology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gambato","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Kwan","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Victor","sequence":"additional","affiliation":[{"name":"Underwood Center for Digestive Disorders, J.C. Walter Jr. Transplant Center, and Sherrie and Allan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo A.","family":"Orci","sequence":"additional","affiliation":[{"name":"Divisions of Transplant and Abdominal Surgery, Department of Surgery, and Hepato-pancreato-biliary Center, University of Geneva Hospitals, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Toso","sequence":"additional","affiliation":[{"name":"Divisions of Transplant and Abdominal Surgery, Department of Surgery, and Hepato-pancreato-biliary Center, University of Geneva Hospitals, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"bib2-20231002","first-page":"171","article-title":"An autopsy case of stunted growth with fatty liver cirrhosis, hepatoma, hypogonadism, osteoporosis and lipid pneumonia","volume":"18","year":"1968","journal-title":"Acta Pathol Jpn"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the Management of non-Alcoholic Fatty Liver Disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/hep.28702","article-title":"Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"e1000094","DOI":"10.1371\/journal.pmed.1000094","article-title":"The GRADE system for rating clinical guidelines","volume":"6","year":"2009","journal-title":"PLoS Med"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1499-3872(11)60120-3","article-title":"Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"11","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.12116","article-title":"Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study","volume":"28","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3748\/wjg.v21.i4.1189","article-title":"Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease","volume":"21","year":"2015","journal-title":"World J Gastroenterol"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","year":"2015","journal-title":"Clin Gstroenterol Hepatol"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/liv.12764","article-title":"Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?","volume":"35","year":"2015","journal-title":"Liver Int"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","article-title":"Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study","volume":"50","year":"2015","journal-title":"J Gastroenterol"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/apt.13505","article-title":"Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer","volume":"43","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/1806-9282.62.03.218","article-title":"Non-alcoholic fatty liver disease (NAFLD) in different populations: a clinical and epidemiological study\u2014sample of S\u00e3o Jos\u00e9 do Rio Preto","volume":"62","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.6061\/clinics\/2016(05)07","article-title":"Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey","volume":"71","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"e0186715","DOI":"10.1371\/journal.pone.0186715","article-title":"Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: an observational study","volume":"12","year":"2017","journal-title":"PloS One"},{"key":"bib24-20231002","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","journal-title":"J Hepatol"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","year":"2005","journal-title":"Gastroenterology"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","article-title":"Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C","volume":"24","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 19","key":"bib29-20231002","first-page":"89","article-title":"Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"44","year":"2009","journal-title":"J Gastroenterol"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ajg.2011.327","article-title":"Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma","volume":"107","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ijc.30784","article-title":"The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease","volume":"141","year":"2017","journal-title":"Int J Cancer"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"bib34-20231002","first-page":"1020","article-title":"American association for the study of liver diseases. Management of Hepatocellular Carcinoma: an update","volume":"42","year":"2010","journal-title":"Hepatology"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmrr.1291","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","year":"2017","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:18:17Z","timestamp":1696209497000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002361","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}